Drugs / VPA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00867672 | Aug 2011 → Feb 2015 | acute myeloid leukemia | University Hospital Freiburg | Completed | Mixed |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00867672 ↗ |
| Action | Inhibit | “histone deacetylase inhibitor valproate” PMID 31794324 ↗ Dec 2019 |
| Route | Oral | “VPA (p.o.) from day 6 of first cycle continuously throughout all treatment cycles” NCT00867672 ↗ |